Argatroban and renal replacement therapy in a morbidly obese patient with heparin-induced thrombocytopenia: A case report

Thrombosis Research

Volumn 126, Issue 2, 2010, Pages

  Godier, Anne ^a   Flaujac, Claire ^a   Horellou, Marie Hélène ^a   De Mesmay, Marine ^a   Bécanne, Xavier ^a   Parisot, Marion ^a   Gauzit, Rémy ^a   Samama, Charles Marc ^a  

^a HÔTEL DIEU   (France)

Author keywords

Argatroban; Obesity; Renal replacement therapy; Reparin induced thrombocytopenia

Indexed keywords

ARGATROBAN; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 6; DANAPAROID; HEPARIN; LEPIRUDIN; POLYSULFONE; THROMBOPLASTIN; WARFARIN;

ABDOMINAL WALL HERNIA; ACUTE KIDNEY FAILURE; ADULT; ANTITHROMBIN DEFICIENCY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; DOPPLER FLOWMETRY; DRUG ACCUMULATION; DRUG DOSE INCREASE; DRUG OVERDOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FILTER; HEMOFILTRATION; HUMAN; INTENSIVE CARE UNIT; INTERNATIONAL NORMALIZED RATIO; LETTER; LOW DRUG DOSE; LUNG EMBOLISM; MAINTENANCE DRUG DOSE; MALE; MORBID OBESITY; OBSERVATION; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; RENAL REPLACEMENT THERAPY; SEPTIC SHOCK; THROMBOCYTOPENIA;

ACUTE KIDNEY INJURY; ADULT; ANTICOAGULANTS; HEPARIN; HUMANS; MALE; OBESITY, MORBID; PIPECOLIC ACIDS; RENAL REPLACEMENT THERAPY; RESPIRATORY DISTRESS SYNDROME, ADULT; SHOCK, SEPTIC; THROMBOCYTOPENIA;

EID: 77955714738     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.12.018     Document Type: Letter

References (20)

1. K. Selleng, T.E. Warkentin, and A. Greinacher Heparin-induced thrombocytopenia in intensive care patients Crit Care Med 35 2007 1165 1176
2. S. Lasocki, P. Piednoir, and N. Ajzenberg Anti-PF4/heparin antibodies associated with repeated hemofiltration-filter clotting: a retrospective study Crit Care 12 2008 R84
3. C. Ronco, R. Bellomo, P. Homel, A. Brendolan, M. Dan, and P. Piccinni Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial Lancet 356 2000 26 30
4. T.E. Warkentin Heparin-induced thrombocytopenia: diagnosis and management Circulation 110 2004 454 458
5. M. Tschudi, B. Lämmle, and L. Alberio Dosing lepirudin in patients with heparin-induced thrombocytopenia and normal or impaired renal function: a single-center experience with 68 patients Blood 113 2009 2402 2409
6. A. Koster, T. Hentschel, and T. Groman Argatroban anticoagulation for renal replacement therapy in patients with heparin-induced thrombocytopenia after cardiovascular surgery J Thorac Cardiovasc Surg 133 2007 1376 1377
7. A. Link, M. Girndt, and S. Selejan Argatroban for anticoagulation in continuous renal replacement therapy Crit Care Med 37 2009 105 110
8. J. Hirsh, K.A. Bauer, and M.B. Donati Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 2008 141S 159S (Pubitemid 351892966)
9. T.E. Warkentin Determinants of donor platelet variability when testing for HIT J Lab Clin Med 120 1992 371 379
10. T. Bakchoul, A. Giptner, A. Najaoui, G. Bein, S. Santoso, and U.J. Sachs Prospective evaluation of PF4/heparin immunoassays for the diagnosis of heparin-induced thrombocytopenia J Thromb Haemost 7 2009 1260 1265
11. B.E. Lewis, D.E. Wallis, and S.D. Berkowitz Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia Circulation 103 2001 1838 1843
12. B.E. Lewis, D.E. Wallis, and F. Leya Argatroban anticoagulation in patients with heparin-induced thrombocytopenia Arch Intern Med 163 2003 1849 1856
13. I.Y. Tang, D.S. Cox, and K. Patel Argatroban and renal replacement therapy in patients with heparin-induced thrombocytopenia Ann Pharmacother 39 2005 231 236
14. P.T. Murray, B.V. Reddy, and E.J. Grossman A prospective comparison of three argatroban treatment regimens during hemodialysis in end-stage renal disease Kidney Int 66 2004 2446 2453
15. T.E. Warkentin, A. Greinacher, and A. Koster Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 2008 340S 380S
16. J.E. Love, C. Ferrell, and W.L. Chandler Monitoring direct thrombin inhibitors with a plasma diluted thrombin time Thromb Haemost 98 2007 234 242
17. J.L. Francis, and M.J. Hursting Effect of argatroban on the activated partial thromboplastin time: a comparison of 21 commercial reagents Blood Coagul Fibrinolysis 16 2005 251 257
18. L. Rice, M.J. Hursting, and G.M. Baillie Argatroban anticoagulation in obese versus nonobese patients: implications for treating heparin-induced thrombocytopenia J Clin Pharmacol 47 2007 1028 1034
19. M.J. Hursting, and I.K. Jang Effect of body mass index on Argatroban therapy during percutaneous coronary intervention J Thromb Thrombolysis 25 2008 273 279
20. N.L. Shapiro, E.A. Durr, and C.D. Krueger Prolonged anticoagulation after discontinuation of argatroban and warfarin therapy in an obese patient with heparin-induced thrombocytopenia Pharmacotherapy 26 2006 1806 1810